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Abstract
Objective: Anotia and microtia are congenital malformations of the external ear with few known 
risk factors. We conducted a comprehensive assessment of a wide range of potential risk factors 
using data from the National Birth Defects Prevention Study (NBDPS), a population-based case-
control study of non-chromosomal structural birth defects in the United States.
Methods: Mothers of 699 infants with anotia or microtia (cases) and 11,797 non-malformed 
infants (controls) delivered between 1997 and 2011 were interviewed to obtain information about 
sociodemographic, health behavioral, and clinical characteristics. Adjusted odds ratios (aORs) and 
95% confidence intervals (CIs) were estimated with logistic regression.
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Results: Infants with anotia/microtia were more likely to be male (aOR, 1.29; 95% CI, 1.10–
1.50) and from a multifetal pregnancy (aOR, 1.68; 95% CI, 1.16–2.42). Cases were also more 
likely to have parents of Hispanic ethnicity (maternal aOR, 3.19; 95% CI, 2.61–3.91; paternal 
aOR, 2.11; 95% CI, 1.54–2.88), and parents born outside the United States (maternal aOR, 1.29; 
95% CI, 1.06–1.57; paternal aOR, 1.92; 95% CI, 1.53–2.41). Maternal health conditions 
associated with increased odds of anotia/microtia included obesity (aOR, 1.31; 95% CI, 1.06–
1.61) and pre-pregnancy diabetes (type I aOR, 9.89; 95% CI, 5.46–17.92; type II aOR, 4.70; 95% 
CI, 2.56–8.63). Reduced odds were observed for black mothers (aOR, 0.57; 95% CI, 0.38–0.85) 
and mothers reporting daily intake of folic acid-containing supplements (aOR, 0.59; 95% CI, 
0.46–0.76).
Conclusion: We identified several risk factors for anotia/microtia, some which have been 
previously reported (e.g., diabetes) and others which we examined for perhaps the first time (e.g., 
binge drinking) that warrant further investigation. Our findings point to some potentially 
modifiable risk factors and provide further leads toward understanding the etiology of anotia/
microtia.
Keywords
birth defect; congenital malformation; anotia; microtia; ear
1. INTRODUCTION
Microtia is a birth defect characterized by a small and/or malformed ear(s). The most severe 
form of microtia is anotia, in which the external ear is completely absent. The prevalence of 
anotia/microtia varies substantially by geographic region [1–6], with the highest prevalence 
of 17.4 per 10,000 newborns reported in Quito, Ecuador [7]. Within the United States, the 
average prevalence between 2011 and 2015 across 30 states with population-based birth 
defects surveillance programs was 1.8 per 10,000 infants [8]. However, a two-fold higher 
prevalence of 2.6 per 10,000 infants was observed in the subset of 12 states with active case-
finding methodology (vs. passive surveillance)[8].
The functional, medical, and psychosocial costs of anotia/microtia are substantial [9–11]. 
Hearing loss is present in 90% of cases [12–13], and rehabilitation can be challenging. 
Often, rehabilitation cannot be accomplished through surgery alone and requires hearing 
aids [14]. The aesthetic component of the reconstruction process typically requires multiple 
surgical stages, and occurrence of complications can exceed 70% [14–15].
Anotia/microtia is sometimes associated with craniofacial syndromes, including Fraser, 
Treacher-Collins, and Goldenhaar Syndromes, as well as the chromosomal trisomies [6,16], 
but there are no confirmed single-gene mutations for non-syndromic cases. Other birth 
defects that may co-occur with anotia/microtia include vertebral anomalies, macrostomia, 
oral clefts, facial asymmetry, renal abnormalities, heart defects, microphthalmia, 
holoprosencephaly, and polydactyly [5,6,16–18]. However, 25–45% of cases are neither 
associated with a syndrome nor another defect [2,16]. The majority of these non-syndromic, 
isolated cases are presumed to be sporadic [6,19].
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Few risk factors for anotia/microtia have been identified. Relatively well-established factors 
include male sex [2,4,5,16], Hispanic ethnicity [2,3,20,21], and maternal diabetes [6,22–24]. 
Other risk factors that have been suggested include advanced maternal age [2,4,5], high 
parity [5,7], multifetal gestation [24], low maternal educational achievement [2,3,16,21,25], 
American Indian/Alaskan Native [20] or Asian/Pacific Islander [4,20,26] ethnicity, and birth 
outside the US specifically among Hispanic mothers [21,23]. Teratogenic medications 
known to cause anotia/microtia include thalidomide, isotretinoin, and mycophenolate 
mofetil [27–29]. Pre-pregnancy obesity [21,30,31] and low periconceptional folic acid/folate 
intake [30,32] are among the few potentially modifiable risk factors.
We conducted a comprehensive assessment of potential sociodemographic, health 
behavioral, and clinical risk factors for anotia/microtia in a population-based study.
2. METHODS
2.1 Study population
The National Birth Defects Prevention Study (NBDPS) was a case-control study of over 30 
types of major structural birth defects. Ten Centers for Birth Defects Research and 
Prevention (henceforth, “centers”) participated in the NBDPS, which was sponsored by the 
Centers for Disease Control and Prevention (CDC). Details of the NBDPS design are 
published [33]. Briefly, cases with an eligible birth defect were identified by population-
based birth defects surveillance registries with active case ascertainment approaches in 
Arkansas, California, Iowa, Massachusetts, New Jersey, New York, Texas, Georgia, North 
Carolina, and Utah. Cases were ascertained among live-born infants, stillborn fetuses (≥ 20 
weeks), and elective terminations. Infants without any major birth defect were selected as 
controls through random sampling of birth certificates or birth hospital records at each 
center from the same time- and geographic-frame as cases [34]. All cases and controls had 
an estimated delivery date (“due date”) between November 1997 and December 2011. 
Pregnancies with donor gamete(s) or embryos (3 cases and 32 controls) were excluded from 
our study sample.
2.2 Case classification
Cases of anotia/microtia (British Paediatric Association (BPA) codes 744.010–14 and 
744.210–14) diagnosed at postnatal examination, surgical repair, or autopsy were 
ascertained up to one or (for some centers) two years after delivery by each center’s birth 
defects registry. Abstracted medical records for each infant with anotia or microtia were 
reviewed by a clinical geneticist at each center and again by a study-wide clinician (AES) to 
confirm that the case definition for eligibility was met, and to ensure consistent classification 
across all centers. Details of the NBDPS classification scheme are published [35].
Eligible cases of anotia/microtia included type 2 (moderately anomalous ear), type 3 
(rudimentary soft tissue structure with no cartilage), and type 4 (anotia). Cases with type 1 
microtia (normally shaped, but smaller ear) or those described only as “small ears” were 
excluded, as were cases with only abnormal external auditory canals. Also excluded from 
the NBDPS were any cases with known chromosomal abnormalities, single-gene disorders, 
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or syndromes. Eligible cases of anotia/microtia were further classified by the presence or 
absence of cooccurring defects: cases were classified as isolated if anotia/microtia occurred 
alone or with a minor defect (e.g., tongue tie, stenosis of lacrimal duct, or flat nasal bridge), 
or non-isolated if another major structural birth defect was present. Laterality (unilateral/
bilateral) was also documented.
2.3 Risk factor assessment
Maternal self-reported information about demographics, health conditions and behaviors, 
paternal factors, and pregnancy characteristics were collected through a structured, 
computer-assisted telephone interview. Mothers were interviewed in English or Spanish 
between 6 weeks and 24 months after the estimated date of delivery; the average time-to-
interview for cases and controls was 11 and 9 months, respectively. Among mothers of 
eligible cases of anotia/microtia, 68% participated in the interview (64% among mothers of 
controls); non-interviewed cases and controls were excluded from this analysis.
All potential risk factors assessed in this analysis were ascertained during the maternal 
interview. Maternal demographic factors of interest included age at delivery (<25, 25–34, 
>35 years), race/ethnicity (white, non-Hispanic; black, non-Hispanic; Hispanic; other 
[Asian, Pacific Islander, Native American, Alaskan Native, or self-identified other]), 
birthplace (US, non-US), and education level (<high school, high school, >high school). 
Health behaviors of interest were folic acid supplementation with a single vitamin, prenatal 
vitamin or multivitamin containing folic acid during the first trimester and month before 
pregnancy (no use, non-daily use [less than daily use], and daily use), cigarette use during 
the first trimester (none, 1–4 cigarettes/day, ≥5 cigarettes/day [equivalent to ≥1/2 a pack/
day]), alcohol use during the first trimester and month before pregnancy (none; binge 
drinking of ≥4 drinks on one occasion with each drink defined as one glass of wine, beer, 
mixed drink or shot of liquor; drinking, but not binge drinking), substance abuse in the three 
months before pregnancy until delivery (no, yes, including any recreational or illicit drug 
use), and caffeine intake (<10, 10–99, 100–199, 200–299, <300 milligrams, derived from a 
continuous variable based on maternal consumption of coffee, tea, soda, and chocolate and 
categorized based on one cup of coffee intervals since each cup contains approximately 100 
milligrams). Clinical factors of interest included self-reported first-degree family history of 
anotia/microtia (no, yes), number of prior live births (0, 1, 2, ≥3), pre-pregnancy body mass 
index (BMI) (<18.5, 18.5–25, 25–30, >30 kg/m2 according to the National Institute of 
Health categories), history of asthma (no, yes for any history of an asthma diagnosis), and 
history of diabetes (no, any history of type I, type II, or gestational). We also assessed 
several paternal factors including age at delivery, race/ethnicity, birthplace, education level, 
and substance abuse. Lastly, we assessed the following pregnancy characteristics: infant sex 
(female, male), plurality (singleton, multifetal gestation), and gestational age at delivery 
(<32 weeks or very preterm, 32–36 weeks or preterm, ≥37 weeks or term).
2.4 Statistical analysis
Univariate and bivariate analyses were performed to explore the relationships between case 
status and the potential risk factors described above. Logistic regression was used to 
estimate odds ratios (ORs), adjusted odds ratios (aORs) and 95% confidence intervals (CIs) 
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for each factor of interest. To assess the potential for confounding, we constructed directed 
acyclic graphs (DAG) informed by previous studies and biologic plausibility [36,37]. 
Potential maternal confounders were age, race/ethnicity, birthplace, education level, number 
of prior live births, pre-pregnancy BMI, smoking, alcohol use, substance abuse, caffeine 
intake, and diabetes. Potential paternal confounders were age, race/ethnicity, birthplace, and 
education level. For each potential risk factor of interest, we began with a fully adjusted 
model and, using backward selection, retained only covariates that changed the magnitude of 
the estimated association by at least 10%.
In models estimating the association between folic acid-containing supplementation and 
anotia/microtia, we further assessed effect measure modification by obesity, maternal race/
ethnicity, and birthplace with multiplicative interaction terms. These factors were chosen 
based on substantial biologic rationale and evidence from previous studies [30,38,39]. 
Greater than 10% differences in stratum specific estimates were considered substantially 
different. The likelihood ratio tests (LRT) and Wald p-values of the interaction terms were 
evaluated at an alpha-level of 0.05 to determine benefit to the model from their inclusion.
In a series of secondary analyses, we estimated adjusted ORs stratified by the presence of 
co-occuring defects (isolated vs. non-isolated), laterality (unilateral vs. bilateral), and infant 
sex. We also repeated analyses excluding mothers with pre-gestational type I or type II 
diabetes, given the previously reported strong association between pre-existing diabetes and 
anotia/microtia [6,22–24].
The NBDPS is approved by the Institutional Review Boards (IRB) of the CDC and all 
participating centers. Recruited participants provided informed consent to participate in the 
NBDPS prior to the maternal interview. For this analysis, additional IRB approval was 
obtained by the University of North Carolina at Chapel Hill (study #16–2460). Data were 
analyzed using SAS statistical software version 9.4 (SAS institute, Inc., Cary, NC, USA).
3. RESULTS
Our study sample consisted of mothers of 699 anotia/microtia cases and 11,797 controls. 
Among the cases, 480 (69%) had isolated anotia/microtia and 219 (31%) were non-isolated. 
There were 608 (87%) unilateral defects, 88 (13%) bilateral defects, and 3 (<1%) cases with 
unspecified laterality. The majority of anotia/microtia cases were livebirths (>98%); 3 and 7 
of the cases were stillbirths and terminations, respectively.
The distribution of maternal, paternal, and pregnancy characteristics by case/control status is 
presented in Table 1. Infants with anotia/microtia were more likely to be male, part of a 
multi-fetal pregnancy, and delivered preterm. The proportion of cases and controls with a 
first-degree family history of anotia/microtia was similar. Mothers of cases were more likely 
to have a lower annual household income (≤$50,000), though the proportion of participants 
with missing information for income was relatively high (nearly 10%). The proportion of 
cases differed across the ten centers, as did the distribution of race/ethnicity.
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3.1 Pregnancy characteristics
Associations between pregnancy characteristics and anotia/microtia are presented in Table 2. 
Increased odds were observed for males (OR, 1.29; 95% CI, 1.10–1.50) and non-singletons 
(OR, 1.68; 95% CI, 1.16–2.42). Cases were also more likely to be delivered preterm (OR, 
2.46; 95% CI, 1.99–3.03) or very preterm (OR, 3.63; 95% CI, 2.42–5.45), particularly those 
with non-isolated anotia/microtia.
3.2 Maternal factors
Crude and adjusted ORs for selected maternal sociodemographic, clinical, and health 
behavioral factors are presented in Table 3 for all cases of anotia/microtia combined, as well 
as stratified by isolated/non-isolated classification. Increased odds were identified for 
maternal Hispanic race/ethnicity (aOR, 3.19; 95% CI, 2.61–3.91), ‘other’ race/ethnicity 
(aOR, 1.79; 95% CI, 1.30–2.46), and maternal birth outside the US (aOR, 1.2; 95% CI, 
1.06–1.57). The strong association with maternal Hispanic race/ethnicity was observed for 
both isolated and non-isolated cases, whereas the association with non-US birthplace 
appeared to be only among cases with isolated anotia/microtia. Reduced odds of anotia/
microtia were observed for black mothers (aOR, 0.57; 95% CI, 0.38–0.85), particularly 
among isolated cases, as compared with white, non-Hispanic mothers.
Mothers with high pre-pregnancy BMI (obese) were more likely to have an infant with 
anotia/microtia (OR, 1.31; 95% CI, 1.06–1.61), though this association was attenuated to 
null in sensitivity analyses excluding all women with a history of diabetes (data not shown). 
We observed ten-fold and five-fold increased odds for type I (aOR, 9.89; 95% CI, 5.46–
17.92) and type II (aOR, 4.70; 95% CI, 2.56–8.63) diabetes, respectively, though the 
confidence intervals were wide. The associations with type I and II diabetes were 
substantially stronger for non-isolated cases. We observed an association for gestational 
diabetes among non-isolated cases (aOR, 1.62; 95% CI, 1.04–2.52), but not for isolated 
cases or for all cases combined.
Reduced odds were also observed for any use of periconceptional folic acid supplementation 
compared to no supplementation, particularly for daily use (aOR, 0.59; 95% CI, 0.46–0.76). 
There was effect measure modification of this association by maternal birth outside the US 
(p=0.003); among mothers born outside the US, the protective effect of daily supplement 
intake was stronger in magnitude (aOR, 0.33; 95% CI, 0.19–0.58). For mothers born in the 
US, there was no association with folic acid-containing supplement intake for any frequency 
of use (daily or non-daily). We observed no association with maternal alcohol use, with the 
possible exception of binge drinking and bilateral anotia/microtia (aOR, 1.84; 95% CI, 1.06–
3.21) (Supplemental Table). Smoking ≥5 cigarettes/day was associated only with non-
isolated cases of anotia/microtia. There were no significant associations with maternal age at 
delivery, education, number of prior live births, history of asthma, substance abuse, or 
caffeine intake.
The aORs estimated separately for unilateral vs. bilateral defects and male vs. female cases 
are presented in the Supplemental Table. The strong association with maternal Hispanic 
race/ethnicity persisted in all subgroups evaluated. The increased odds with maternal birth 
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outside the US was attenuated for bilateral defects. The increased odds with type I and II 
diabetes were both higher for bilateral compared to unilateral defects. There was no 
significant association for gestational diabetes for all cases together, however, there were 
significantly elevated aORs for gestational diabetes in the bilateral and female cases.
3.3 Paternal factors
Crude and adjusted ORs for selected paternal characteristics are presented in Table 4 for all 
cases of anotia/microtia combined, as well as stratified by isolated/non-isolated 
classification. For all anotia/microtia cases combined, an increased association was observed 
for paternal Hispanic race/ethnicity even after adjustment for maternal race/ethnicity (aOR, 
2.11; 95% CI, 1.54–2.88). As with maternal Hispanic race/ethnicity, this strong association 
persisted in all subgroups evaluated (see also Supplemental Table). Increased odds were also 
observed for paternal birth outside the US (aOR, 1.92; 95% CI, 1.53–2.41). No associations 
were observed for paternal age, education, or substance abuse.
4. DISCUSSION
The relatively low prevalence of anotia/microtia in the general population has limited the 
epidemiologic study of potential risk factors for this major structural defect. The large 
number of cases in NBDPS and rich interview data affords a unique opportunity for a 
comprehensive assessment of a broad range of risk factors for non-syndromic anotia/
microtia. The analysis updates and extends previous analyses conducted in a subset of our 
NBDPS study population [21,22,24,30,32,40,41]. Our study expands upon these earlier 
studies by including four additional years (2008–2011) and almost 200 additional cases. Our 
study also includes previously uninvestigated risk factors such as maternal binge drinking, 
substance use, number of prior live births, and maternal history of asthma, as well as 
paternal age, race/ethnicity, and education.
The increased risk we confirmed for male infants has been already well established in 
various populations [2,4,5,16]. This analysis also confirms prior findings that the association 
with male sex is driven mostly by unilateral and isolated rather than the bilateral and non-
isolated cases, which are more evenly distributed by sex [5].
Our results are also consistent with previous studies that have reported increased risk of 
anotia/microtia with Hispanic maternal ethnicity [2,3,20,21], American Indian/Alaskan 
Native/Asian/Pacific Islander/other maternal ethnicity [4,20,26], maternal birth outside the 
US [2,21], multifetal gestation [24], diabetes [6,22–24], and lower folic acid/folate intake 
[30, 32]. Our study is also consistent with previous reports of lower odds of anotia/microtia 
among black mothers [2,20]. Notably, our analysis identified new potential risk factors for 
further investigation including paternal Hispanic race/ethnicity (independent of maternal 
race/ethnicity), smoking of ≥5 cigarettes/day (for non-isolated cases), and binge drinking 
(for bilateral defects).
The association with Hispanic ethnicity may be related to lifestyle or immigration and 
acculturation. In the NBDPS study population, the majority of parents born outside the US 
are Hispanic (69% of both mothers and fathers). Previous NBDPS analyses have shown that 
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maternal birth outside the US increases risk of anotia/microtia among Hispanic mothers 
[21,39]. Specifically, in an analysis of 163 cases, Ramadhani et al. (2009) found that 
Hispanic immigrants have a higher risk of having a child with anotia/microtia than Hispanic-
Americans born in the US (aOR, 1.60; 95% CI, 1.06–2.42)[39]. Hoyt et al. (2014) showed 
that maternal emigration from Mexico after age 5 (aOR, 4.88; 95% CI, 2.93–8.11) portends 
a particularly high risk [21]. Both of these analyses were of an earlier subset of the NBDPS 
population and our results show a similar increased risk in mothers born outside the US. We 
also found an increased risk for fathers born outside the US, even after accounting for 
maternal nativity. Similar to race/ethnicity, parental nativity may influence the risk of anotia/
microtia through both environmental and lifestyle factors. However, we did not account for 
heterogeneity in birthplace among non-US born parents, and further investigation is 
required.
A major strength of our study is the rigorous case verification and systematic classification 
scheme. Stratification by isolated and non-isolated occurrences of anotia/microtia allowed us 
to independently evaluate a more etiologically homogenous group of isolated cases, as 
severe cases with multiple cooccurring defects may have different underlying pathogenesis 
[35]. Notably, the decreased odds with black maternal race and folic acid-containing 
supplementation as well as the increased odds with maternal birth outside the US and male 
sex were stronger for isolated cases.
Further, owing to the detailed classification information in NBDPS, we could estimate 
associations stratified by laterality, which is important since bilateral cases may introduce 
phenotypic heterogeneity and may also be more likely related to an unknown syndrome 
[2,6]. However, the relatively few bilateral defects in our study group (n=88, 12.6%) limited 
analytic precision. The moderately increased risk with maternal binge drinking for bilateral 
defects was not present overall or in any other subgroup, and requires further investigation. 
The stronger association noted for bilateral cases and maternal diabetes, particularly for pre-
pregnancy type I/II diabetes, supports the diabetic embryopathy theory proposed by Van 
Bennekom et al. (2013) that hyperglycemia induced disruption of ear development may 
contribute more to the development of bilateral defects [24]. The strength of the association 
with all types of diabetes also increased for non-isolated defects and this may have been due 
to the wide fluctuations in blood glucose in diabetes that lead to varied structural defects 
during different time points in embryologic development [42]. Those with gestational 
diabetes can still be euglycemic during the first trimester, which could explain the weaker 
association compared to pre-existing type I/II diabetes.
The diabetic embryopathy etiology also suggests that obese mothers would have a higher 
risk of offspring with anotia/microtia, since glucose intolerance is more common with 
obesity even in the absence of a diabetes diagnosis. The 1.31 times higher odds of anotia/
microtia in obese mothers (95% CI, 1.06–1.61) is similar to analyses in earlier subsets of the 
NBDPS population including those by Ma et al. (2010) (1997–2005; OR, 1.27; 95% CI, 
0.96–1.67) and Waller et al. (2007) (1997–2002; aOR, 1.10; 95% CI, 0.74–1.65) [30,31].
Because of the known strong association with type I/II diabetes, a sensitivity analysis 
excluding mothers with pre-gestational diabetes was performed. This exclusion slightly 
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attenuated the already weak association with obesity, suggesting that this association may be 
related to concomitant diabetes or elevated glucose levels in those mothers rather than 
independent changes caused by the pathophysiology of obesity.
There may be an interplay between folate levels and diabetes. Folate is essential to normal 
embryogenesis and cell proliferation. Folic acid supplementation reduced malformations in 
animal embryos exposed to high glucose concentrations that simulate diabetes [43,44]. 
Folate status in pregnant women is influenced by both dietary folate and supplemental folic 
acid intake. In an earlier subset of the NBDPS data, Ma et al. (2012) found an association 
between anotia/microtia and low dietary folate intake (OR, 1.57; 95% CI, 1.09–2.25)[32]. 
Ma et al. (2010) also showed a decreased odds with periconceptional folic acid-containing 
supplementation (OR, 0.81; 95% CI, 0.59–1.10) in an analysis of 420 cases [30]. Our 
analysis of folic acid-containing supplementation, which included additional NBDPS 
participants, had a smaller aOR with a narrower CI. Further, the analysis by Ma et al. (2010) 
found a decreased odds with folic acid-containing supplementation in non-obese women 
(aOR, 0.63; 95% CI, 0.44–0.91), but not in obese women (aOR, 1.51; 95% CI, 0.69–3.28), 
suggesting a different biologic effect of folic acid based on BMI [30]. However, there was no 
statistical evidence of effect measure modification of folic acid-containing supplementation 
by obesity in our analysis.
There was effect measure modification of folic acid-containing supplementation by maternal 
nativity in our analysis. After stratifying by maternal nativity, the significantly reduced odds 
only persisted in women not born in the US who also took daily supplements. This may be 
due to recall error about supplementation or could possibly reflect differences in dietary 
sources of folate between mothers based on nativity. Serum folate levels are lower in 
Hispanic compared to non-Hispanic white women in the US [38]. This may in part be due to 
lower consumption of cereals and enriched grains, which are required to be fortified with 
folic acid in the US, and higher consumption of staple foods made with corn flour (masa), 
which was not fortified during the study period. To address folate insufficiency and neural 
tube defects (NTDs) in this population, the U.S Food and Drug Administration recently 
authorized voluntary fortification of corn flour in 2016 [45]. Many other countries do not 
have any mandatory folate fortification. Women who lived in countries without fortification 
or who had a corn flour-based diet during the periconceptional period may experience a 
larger benefit from folic acid supplementation. US-born women who eat a fortified grain-
based diet and have adequate folate stores may receive less added protection from additional 
folic acid supplementation. Anotia/microtia could decrease along with NTDs as more 
countries fortify their grain products and as more corn flour is fortified in the US.
The suggestion that poor quality periconceptional diets and lack of folic acid have 
contributed to the excess of NTDs and anotia/microtia found in mothers born outside the US 
has been previously suggested by Ramadhani et al. (2009), who found similarly elevated 
odds of anotia/microtia (aOR, 1.60; 95% CI, 1.06–2.42) and spina bifida (aOR, 1.53; 95% 
CI; 1.06–2.35) in NBDPS mothers born in Central America or Mexico [39]. The critical 
period of external ear development occurs later than neural tube closure, starting after the 
first month of pregnancy and extending through the third month of pregnancy [46]. 
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Adequate nutrition and folate levels may be most important during this period to prevent 
anotia/microtia.
Our results were not consistent with previously reported associations with advanced 
maternal age [2,4,5], high parity [5,7], and low educational achievement [2,3,16,21,25]. In 
our analysis, the elevated OR for less than a high school maternal education compared to 
high school education did not persist after adjustment for race/ethnicity.
Despite the rigorous case classification scheme in the NBDPS, there are some limitations to 
the available clinical data. Given the population-based case-control design, the source of 
clinical information about cases in NBDPS is abstracted medical records, which come from 
a large number of independent health care providers across 10 states over a period of 
approximately 15 years. Subsequently, there is variation across records in terminology and 
diagnostic criteria, making it challenging to systematically and accurately differentiate 
between subtle subtypes across the continuum of microtia. Thus, in this analysis, we do not 
distinguish between Types 2–4 of microtia/anotia. The available information was sufficient 
to exclude cases with the least severe phenotype, Type 1 microtia, but it is possible that a 
few additional cases would have been excluded if more uniform information were available. 
Cases with known chromosomal anomalies or single gene disorders are also excluded from 
NBDPS. However, cases were only ascertained up to two years of age and some genetic 
conditions may have been diagnosed after that time, or the relevant information may not 
have been available in the accessible medical record at the time of abstraction. Cases with 
genetic causes may also be more common in the non-isolated and bilateral defect groups 
[2,6], thereby biasing the apparent effect of risk factors in those subgroups when there is an 
underlying genetic etiology.
The percentage of eligible mothers who participated in the interview was less than 70% and 
there is the potential for selection bias due to factors associated with non-participation. 
Retrospectively collected information from mothers is susceptible to recall errors and 
potentially differential recall between cases and controls, which could bias estimates towards 
or away from the null. This bias was limited in the NBDPS by using trained interviewers and 
structured questionnaires with recall aids. Some of the associations were based on low 
numbers of exposed mothers, especially asthma, recreational substance use, first-degree 
family history of anotia/microtia; likewise, some analyses were based on case subgroups 
(e.g., bilateral cases only), which limited the precision of those analyses.
The strengths of the NBDPS include its large population-based study design, which 
leverages case ascertainment from active surveillance programs to limit referral bias. The 
multi-state study population is geographically and ethnically diverse, and has been shown to 
represent the underlying US population relatively well [34]. As noted earlier in Section 2.2, 
confirmation of case diagnosis and eligibility as well as systematic classification is a critical 
strength that reduces phenotypic – and thus likely etiologic – heterogeneity. Lastly, the 
maternal interview yields rich information about a comprehensive set of socio-demographic, 
health behavioral, and clinical factors before and during pregnancy for mothers as well as 
fathers. Findings from this analysis strengthen the existing evidence and point to additional 
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possible risk factors for anotia/microtia that should be further investigated in future analyses 
and in different populations.
Future analyses should consider the effect of risk factors during the critical period of 
external ear development in the second and third month of pregnancy, especially folate levels 
as grain/flour/masa fortification policies change. Though guidelines for periconceptional 
folic acid supplementation to prevent NTDs and anencephaly already exist, including those 
published by the CDC, US Preventive Services Task Forces, American College of 
Obstetricians and Gynecologists, American Academy of Family Physicians, and American 
Academy of Pediatrics [47], future updates of these recommendations could also include 
anotia/microtia. The interaction between folate and oxidating risk factors such as diabetes, 
alcohol and cigarettes should be further explored. Given the heterogeneity of the populations 
at highest risk of anotia/microtia (Hispanic, Asian, and Pacific Islander) further evaluation of 
birthplace and racial/ethnic sub-groups of those mothers and fathers is also warranted. 
Ultimately, prevention recommendations can be targeted to those groups at highest risk for 
anotia/microtia as their underlying risk factors become more fully understood.
5. CONCLUSIONS
We identified several possible risk factors for anotia/microtia, some which have been 
previously observed (e.g., diabetes) and others which we investigated for the first time and 
warrant further investigation (e.g., binge drinking). Our findings point to some potentially 
modifiable risk factors and provide further leads toward understanding the etiology of 
anotia/microtia.
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Table 1.
Maternal, paternal, and pregnancy characteristics of infants with anotia or microtia (cases) compared to infants 
without a major birth defect (controls), National Birth Defects Prevention Study, 1997–2011
Cases (n = 699) n (%) Controls (n = 11,797) n (%)
Pregnancy characteristics
Infant sex
 Male 400 (57.2) 6004 (50.9)
 Female 299 (42.8) 5781 (49.0)
 Missing 0 12 (<1.0)
Plurality
 Singleton 666 (95.3) 11434 (96.9)
 Multifetal gestation 33 (4.7) 338 (2.9)
 Missing 0 25 (<1.0)
Gestational age at delivery
 <32 weeks, very preterm 29 (4.1) 155 (1.3)
 32–36 weeks, preterm 118 (16.9) 931 (7.9)
 ≥37 weeks, term 552 (79.0) 10709 (90.8)
 Missing 0 2 (<1.0)
Maternal socio-demographic factors
Study center (residence at delivery)
 Arkansas 47 (6.7) 1463 (12.4)
 California 165 (23.6) 1261 (10.7)
 Iowa 43 (6.2) 1297 (11.0)
 Massachusetts 57 (8.2) 1393 (11.8)
 New Jersey 53 (7.6) 575 (4.9)
 New York 43 (6.2) 987 (8.4)
 Texas 136 (19.5) 1414 (12.0)
 Georgia 43 (6.2) 1266 (10.7)
 North Carolina 37 (5.3) 1014 (8.6)
 Utah 75 (10.7) 1127 (9.6)
Age at delivery
 <25 years 249 (35.6) 3845 (32.6)
 25–34 years 348 (49.8) 6308 (53.5)
 >35 years 102 (14.6) 1644 (13.9)
Race/ethnicity
 White, non-Hispanic 242 (34.6) 6807 (57.7)
 Black, non-Hispanic 27 (3.9) 1307 (11.1)
 Hispanic 376 (53.8) 2906 (24.6)
 Other 54 (7.7) 770 (6.5)
 Missing 0 7 (<1.0)
Birthplace
 US 406 (58.1) 9070 (76.9)
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Cases (n = 699) n (%) Controls (n = 11,797) n (%)
 non-US 279 (39.9) 2392 (20.3)
 Missing 14 (2.0) 335 (2.8)
Education level
 <high school 200 (28.6) 1905 (16.1)
 high school 170 (24.3) 2724 (23.1)
 >high school 314 (44.9) 6823 57.8)
 Missing 15 (2.1) 345 (2.9)
Household income
 ≤$50,000 476 (68.1) 6763 (57.3)
 >$50,000 156 (22.3) 3862 (32.7)
 Missing 67 (9.6) 1172 (9.9)
Maternal clinical factors
First-degree family history of anotia/microtia
 No 689 (98.6) 11790 (99.9)
 Yes 10 (1.4) 7 (0.1)
Number of prior live births
 0 258 (36.9) 4641 (39.3)
 1 228 (32.6) 3837 (32.5)
 2 118 (16.9) 2026 (17.2)
 ≥3 95 (13.6) 1242 (10.5)
 Missing 0 51 (<1.0)
Body mass index, kg/m2
 <18.5, underweight 29 (4.1) 598 (5.1)
 18.5–25, normal weight 307 (43.9) 6029 (51.1)
 25–30, overweight 145 (20.7) 2546 (21.6)
 >30, obese 138 (19.7) 2070 (17.5)
 Missing 80 (11.4) 554 (4.7)
History of diabetes
 None 590 (84.4) 10809 (91.6)
 Type I 19 (2.7) 34 (0.3)
 Type II 15 (2.1) 49 (0.4)
 Gestational 68 (9.7) 822 (7.0)
 Missing 7 (1.0) 83 (<1.0)
History of asthma
 No 695 (99.4) 11710 (99.3)
 Yes 4 (0.6) 87 (0.7)
Maternal health behaviors
Folic acid supplementation
 No use 224 (32.0) 2687 (22.8)
 Some use, but not daily 336 (48.1) 5587 (47.4)
 Daily use 123 (17.6) 3225 (27.3)
 Missing 16 (2.3) 298 (2.5)
Int J Pediatr Otorhinolaryngol. Author manuscript; available in PMC 2020 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Ryan et al. Page 17
Cases (n = 699) n (%) Controls (n = 11,797) n (%)
Alcohol use
 None 468 (67.0) 7196 (61.0)
 Drinking, but not binge 136 (19.5) 2773 (23.5)
 Binge drinking 80 (11.4) 1429 (12.1)
 Missing 15 (2.1) 399 (3.4)
Cigarette use
 None 596 (85.3) 9713 (82.3)
 1–4 cigarettes/day 28 (4.0) 560 (4.7)
 ≥5 cigarettes/day 64 (9.2) 1210 (10.3)
 Missing 11 (1.6) 314 (2.7)
Substance abuse
 No 649 (92.8) 10859 (92.0)
 Yes 37 (5.3) 634 (5.4)
 Missing 13 (1.9) 304 (2.6)
Daily caffeine intake
 <10 mg 123 (17.6) 2077 (17.6)
 10–99 mg 233 (33.3) 4099 (34.7)
 100–199 mg 170 (24.3) 2630 (22.3)
 200–299 mg 86 (12.3) 1447 (12.3)
 >300 mg 70 (10.0) 1218 (10.3)
 Missing 17 (2.4) 326 (2.8)
Paternal factors
Age at delivery
 <25 years 163 (23.3) 2477 (21.0)
 25–34 years 353 (50.5) 6067 (51.4)
 >35 years 157 (22.5) 2868 (24.3)
 Missing 26 (3.7) 385 (3.3)
Race/ethnicity
 White, non-Hispanic 233 (33.3) 6498 (55.1)
 Black, non-Hispanic 34 (4.9) 1402 (11.9)
 Hispanic 364 (52.1) 2738 (23.2)
 Other 47 (6.7) 684 (5.8)
 Missing 21 (3.0) 475 (4.0)
Birthplace
 US 384 (54.9) 8823 (74.8)
 non-US 296 (42.3) 2538 (21.5)
 Missing 19 (2.7) 436 (3.7)
Education level
 <high school 205 (29.3) 1813 (15.4)
 high school 204 (29.2) 3307 (28.0)
 >high school 252 (36.1) 6001 (50.9)
 Missing 38 (5.4) 676 (5.7)
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Cases (n = 699) n (%) Controls (n = 11,797) n (%)
Substance abuse
 No 607 (86.8) 10210 (86.5)
 Yes 72 (10.3) 1192 (10.1)
 Missing 20 (2.9) 395 (3.3)
US: United States
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Table 2.
Estimated associations between pregnancy characteristics and anotia/microtia, National Birth Defects 
Prevention Study, 1997–2011
All cases (n=699) Isolated anotia/microtia (n=480) Non-isolated anotia/microtia (n=219)
OR (95% CI) OR (95% CI) OR (95% CI)
Infant sex
 Female 1 1 1
 Male 1.29 (1.10, 1.50) 1.36 (1.13, 1.64) 1.15 (0.88, 1.50)
Plurality
 Singleton 1 1 1
 Multifetal gestation 1.68 (1.16, 2.42) 1.24 (0.76, 2.04) 2.67 (1.58, 4.49)
Gestational age at delivery
 <32 weeks, very preterm 3.63 (2.42, 5.45) 1.49 (0.76, 2.94) 10.24 (6.24, 16.80)
 32–36 weeks, preterm 2.46 (1.99, 3.03) 1.49 (1.11, 1.99) 5.45 (4.02, 7.40)
 ≥37 weeks, term 1 1 1
CI: confidence interval, OR: odds ratio
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Table 3.
Estimated associations between anotia/microtia and selected maternal socio-demographic, clinical, and health 
behavioral factors, National Birth Defects Prevention Study, 1997–2011
All cases - unadjusted 
model (n=699)
All cases - adjusted 
model
Isolated cases - 
adjusted (n=480)
Non-isolated cases - 
adjusted (n=219)
OR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Socio-demographic factors
Age at delivera
 <25 years 1.17 (0.99, 1.39) 0.93 (0.78, 1.12) 0.97 (0.78, 1.20) 0.84 (0.61, 1.16)
 25–34 years 1 1 1 1
 >35 years 1.12 (0.90, 1.41) 1.20 (0.96, 1.51) 1.18 (0.90, 1.56) 1.26 (0.85, 1.86)
Race/ethnicityb
 White, non-Hispanic 1 1 1 1
 Black, non-Hispanic 0.58 (0.39, 0.87) 0.57 (0.38, 0.85) 0.37 (0.20, 0.69) 0.91 (0.53, 1.58)
 Hispanic 3.64 (3.08, 4.30) 3.19 (2.61, 3.91) 3.49 (2.73, 4.46) 2.64 (1.87, 3.73)
 Other 1.97 (1.46, 2.67) 1.79 (1.30, 2.46) 1.94 (1.33, 2.83) 1.52 (0.86, 2.69)
Birthplacec
 US 1 1 1 1
 non-US 2.61 (2.22, 3.05) 1.29 (1.06, 1.57) 1.43 (1.14, 1.80) 1.00 (0.71, 1.42)
Education levelc
 <high school 1.68 (1.36, 2.08) 1.14 (0.91, 1.42) 1.10 (0.85, 1.43) 1.24 (0.84, 1.82)
 high school 1 1 1 1
 >high school 0.74 (0.61, 0.89) 0.95 (0.77, 1.16) 1.00 (0.78, 1.27) 0.86 (0.61, 1.21)
Clinical factors
Number of prior live births
 0 1 1 1 1
 1 1.07 (0.89, 1.28) NCd 0.99 (0.79, 1.23)d 1.31 (0.95, 1.80)d
 2 1.05 (0.84, 1.31) NCd 1.04 (0.80, 1.35)d 0.92 (0.60, 1.40)d
 ≥3 1.38 (1.08, 1.76) NCd 1.09 (0.80, 1.47)d 1.40 (0.91, 2.15)d
Body mass index, kg/m2
 <18.5, underweight 0.95 (0.64, 1.41) NCd 0.96 (0.60, 1.53)d 0.94 (0.47, 1.86)d
 18.5–25, normal weight 1 1 1 1
 25–30, overweight 1.12 (0.91, 1.37) NCd 0.96 (0.60, 1.53)d 0.88 (0.60, 1.29)d
 >30, obese 1.31 (1.06, 1.61) NCd 1.15 (0.89, 1.49)d 1.65 (1.18, 2.31)d
History of diabetesc
 None 1 1 1 1
 Type I 10.24 (5.80, 18.06) 9.89 (5.46, 17.92) 4.93 (1.99, 12.18) 23.48 (12.03, 45.83)
 Type II 5.61 (3.13, 10.06) 4.70 (2.56, 8.63) 1.31 (0.40, 4.28) 13.91 (7.17, 26.96)
 Gestational 1.52 (1.17, 1.97) 1.26 (0.97, 1.64) 1.14 (0.83, 1.57) 1.62 (1.04, 2.52)
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All cases - unadjusted 
model (n=699)
All cases - adjusted 
model
Isolated cases - 
adjusted (n=480)
Non-isolated cases - 
adjusted (n=219)
OR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
History of asthmac
 No 1 1 1 1
 Yes 0.77 (0.28, 2.12) 0.96 (0.35, 2.65) 0.73 (0.18, 2.99) 1.45 (0.35, 5.94)
Health behaviors
Folic acid supplementation
 No use 1 1 1 1
 Some use, but not daily 0.72 (0.61, 0.86) 0.81 (0.67, 0.97) 0.73 (0.59, 0.90) 1.04 (0.75, 1.45)
 Daily use 0.46 (0.37, 0.57) 0.59 (0.46, 0.76) 0.52 (0.39, 0.70) 0.80 (0.52, 1.24)
Alcohol usec
 None 1 1 1 1
 Drinking, but not binge 0.75 (0.62, 0.92) 0.97 (0.79, 1.18) 1.01 (0.79, 1.28) 0.87 (0.61, 1.24)
 Binge drinking 0.86 (0.67, 1.10) 1.06 (0.83, 1.36) 1.03 (0.76, 1.39) 1.13 (0.75, 1.71)
Cigarette usec
 None 1 1 1 1
 1–4 cigarettes/day 0.81 (0.55, 1.20) 0.93 (0.63, 1.37) 0.91 (0.57, 1.46) 0.96 (0.49, 1.90)
 ≥5 cigarettes/day 0.86 (0.66, 1.12) 1.29 (0.98, 1.70) 1.07 (0.75, 1.54) 1.70 (1.12, 2.59)
Substance abusea
 No 1 1 1 1
 Yes 0.98 (0.69, 1.37) NCd 0.84 (0.54, 1.29)d 1.29 (0.76, 2.20)d
Daily caffeine intakec
 <10 mg 1 1 1 1
 10–99 mg 0.96 (0.77, 1.20) 0.92 (0.73, 1.15) 0.95 (0.72, 1.25) 1.09 (0.74, 1.59)
 100–199 mg 1.09 (0.86, 1.39) 1.01 (0.79, 1.29) 1.09 (0.81, 1.45) 0.86 (0.56, 1.32)
 200–299 mg 1.00 (0.76, 1.33) 1.07 (0.81, 1.43) 1.08 (0.76, 1.53) 1.08 (0.67, 1.75)
 >300 mg 0.97 (0.72, 1.31) 1.14 (0.84, 1.56) 1.09 (0.74, 1.59) 1.24 (0.75, 2.05)
aOR: adjusted odds ratio, CI: confidence interval, NC: not calculated, OR: odds ratio, US: United States
a
Multivariable models were adjusted for maternal education.
b
Multivariable models were adjusted for maternal birthplace.
c
Multivariable models were adjusted for maternal race/ethnicity.
dAdjusted estimates not calculated because no confounder(s) were identified for model inclusion.
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Table 4.
Estimated associations between paternal characteristics and anotia/microtia in offspring, National Birth 
Defects Prevention Study, 1997–2011
All cases - unadjusted 
model (n=699)
All cases - adjusted 
model
Isolated cases - adjusted 
(n=480)
Non-isolated cases - 
adjusted (n=219)
OR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Age at deliverya
 <25 years 1.13 (0.93, 1.37) 0.86 (0.67, 1.10) 0.81 (0.61, 1.09) 0.98 (0.63, 1.51)
 25–34 years 1 1 1 1
 >35 years 0.94 (0.78, 1.14) 0.89 (0.71, 1.12) 0.83 (0.63, 1.10) 1.04 (0.71, 1.54)
Race/ethnicityb
 White, non-Hispanic 1 1 1 1
 Black, non-Hispanic 0.68 (0.47, 0.97) 0.98 (0.56, 1.72) 0.71 (0.33, 1.52) 1.59 (0.69, 3.68)
 Hispanic 3.71 (3.13, 4.40) 2.11 (1.54, 2.88) 1.81 (1.25, 2.63) 2.89 (1.70, 4.91)
 Other 1.92 (1.39, 2.65) 1.45 (0.98, 2.14) 1.36 (0.85, 2.18) 1.62 (0.82, 3.19)
Birthplacec
 US 1 1 1 1
 non-US 2.68 (2.29, 3.14) 1.92 (1.53, 2.41) 2.06 (1.57, 2.69) 1.66 (1.11, 2.47)
Education leveld
 <high school 1.83 (1.50, 2.24) 1.18 (0.95, 1.45) 1.31 (1.02, 1.69) 0.91 (0.63, 1.33)
 high school 1 1 1 1
 >high school 0.68 (0.56, 0.82) 0.87 (0.71, 1.06) 0.93 (0.73, 1.19) 0.77 (0.55, 1.07)
Substance abuse
 No 1 1 1 1
 Yes 1.02 (0.79, 1.31) NCe 0.91 (0.66, 1.24)e 1.26 (0.84, 1.90)e
aOR: adjusted odds ratio, CI: confidence interval, NC: not calculated, OR: odds ratio, US: United States
a
Multivariable models were adjusted for maternal age and paternal education.
b
Multivariable models were adjusted for maternal race/ethnicity.
c
Multivariable models were adjusted for maternal birthplace.
d
Multivariable models were adjusted for paternal race/ethnicity.
eAdjusted estimates not calculated because no confounder(s) were identified for model inclusion.
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